T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HUT
1426
Hut 8
HUT
$10.8B
| $4.34M | ﹤0.01% |
94,523
+20,001
| +27% | +$882K |
|
1427
New Jersey Resources
NJR
$5.66B
| $4.34M | ﹤0.01% |
94,112
+5,027
| +6% | +$232K |
|
1428
Cipher Digital
CIFR
$7.44B
| $4.33M | ﹤0.01% |
293,594
+78,593
| +37% | +$1.39M |
|
1429
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
| $4.33M | ﹤0.01% |
30,708
| – | – |
|
1430
Thor Industries
THO
$4.1B
| $4.33M | ﹤0.01% |
42,166
+1,645
| +4% | +$171K |
|
1431
Radian Group
RDN
$4.95B
| $4.32M | ﹤0.01% |
120,094
+3,866
| +3% | +$135K |
|
1432
Champion Homes
SKY
$5.18B
| $4.31M | ﹤0.01% |
51,016
+1,160
| +2% | +$91.4K |
|
1433
Mueller Water Products
MWA
$3.98B
| $4.3M | ﹤0.01% |
180,539
-143,361
| -44% | -$3.55M |
|
1434
Gentex
GNTX
$5.02B
| $4.28M | ﹤0.01% |
183,782
+10,212
| +6% | +$246K |
|
1435
CarMax
KMX
$8.48B
| $4.28M | ﹤0.01% |
110,696
-107,154
| -49% | -$4.29M |
|
1436
QuantumScape Corp
QS
$3.83B
| $4.28M | ﹤0.01% |
410,338
+74,674
| +22% | +$1.03M |
|
1437
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.6B
| $4.27M | ﹤0.01% |
91,275
-5,500
| -6% | -$259K |
|
1438
Bath & Body Works
BBWI
$3.89B
| $4.26M | ﹤0.01% |
212,158
-842,451
| -80% | -$18.6M |
|
1439
Murphy Oil
MUR
$5B
| $4.2M | ﹤0.01% |
134,460
+6,370
| +5% | +$192K |
|
1440
Meritage Homes
MTH
$4.77B
| $4.2M | ﹤0.01% |
63,790
+1,640
| +3% | +$114K |
|
1441
Chord Energy
CHRD
$7.51B
| $4.19M | ﹤0.01% |
45,224
+2,150
| +5% | +$199K |
|
1442
Banco Santander Chile
BSAC
$16.2B
| $4.18M | ﹤0.01% |
134,397
-41,838
| -24% | -$1.22M |
|
1443
iShares MSCI India ETF
INDA
$6.55B
| $4.18M | ﹤0.01% |
77,250
+6,032
| +8% | +$325K |
|
1444
Genworth Financial
GNW
$3.83B
| $4.17M | ﹤0.01% |
461,910
+7,960
| +2% | +$69.3K |
|
1445
Telephone and Data Systems
TDS
$4.03B
| $4.17M | ﹤0.01% |
101,671
+1,792
| +2% | +$69.8K |
|
1446
Matsons
MATX
$6.48B
| $4.15M | ﹤0.01% |
33,564
+236
| +0.7% | +$25.4K |
|
1447
KBR
KBR
$4.85B
| $4.14M | ﹤0.01% |
103,024
+5,935
| +6% | +$254K |
|
1448
Brookfield Renewable
BEPC
$6.63B
| $4.14M | ﹤0.01% |
108,010
+8,092
| +8% | +$326K |
|
1449
White Mountains Insurance
WTM
$5.11B
| $4.14M | ﹤0.01% |
1,990
+108
| +6% | +$211K |
|
1450
Sabra Healthcare REIT
SBRA
$5.18B
| $4.13M | ﹤0.01% |
217,995
+12,835
| +6% | +$238K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.